(Credit-Canva)
Headaches are a common symptom of a stressful lifestyle, your body not feeling well and other issues. While headaches can be dealt with easily, migraines are not so easy to handle. Migraines are a type of headache that feels like severe throbbing and pulsing sensation, almost like you are hearing your own heartbeat in your brain, usually on one side of the brain. Many people believe that migraines are not that big of a deal because you just have to deal with the pain, but that is not all migraine is, some people find it very difficult to do their daily tasks as they experience dizzying spells, nausea and extreme sensitivity to light and sound! These attacks can last hours and make it difficult for people to go about their daily lives as well. While there are medications available for migraine patients, these medications need time to take effect, so you may be in a lot of pain, but there are not many quick reliefs you can have in place other than learning the symptoms of a migraine attack and taking medication before it happens. But a new approval by the FDA may change this!
The U.S. Food and Drug Administration (FDA) has approved Symbravo, a new medicine to treat acute migraine attacks in adults. This means adults can now use Symbravo to get relief from their migraine symptoms. The FDA's decision was based on the results of three big studies, called Phase 3 trials. These trials involved over 21,000 migraine attacks, so the FDA has a lot of information about how well Symbravo works and how safe it is. The FDA only approves medicines that have been shown to be both safe and effective through a thorough testing process.
"Migraine attacks can happen suddenly and really mess up people's lives. It's estimated that over 39 million people in the U.S. alone get migraines," said Herriot Tabuteau, M.D., CEO of Axsome Therapeutics told US News. This shows how common migraines are and how important it is to have good treatments. "Symbravo gives patients and doctors a new option that can quickly stop a migraine attack, keep it away, and let people get back to their normal activities, all with just one dose." Having a medicine that can give fast and long-lasting relief from migraine pain is a big deal for millions of people. This new treatment is a real step forward in how we treat migraines.
The trials took place in 3 steps, the Momentum trial study focused on people whose migraines had moderate to severe pain. The results showed that a lot more people taking Symbravo felt pain-free two hours after taking the medicine compared to those who took a placebo which is a dummy pill. Even better, many people felt relief for up to 24 and even 48 hours after just one dose. This long-lasting relief is really important for people with migraines because it means they can get back to their normal lives without worrying about the pain coming back. The study also looked at how many people were free from their worst symptom, like sensitivity to light or sound, or nausea. Symbravo worked better than the placebo in this area too.
While the intercept trial looked at people who took Symbravo when their migraine pain was still mild. Even when the pain was just starting, Symbravo was effective. The results were similar to the MOMENTUM trial, with many people getting pain relief and relief from their worst symptoms. Treating migraines early is often better because it can stop the pain from getting really bad.
And lastly the Movement trial which was to see how safe the medication is when people take it regularly. This study followed 706 people who had at least two migraines a month. The most common side effects people experienced were sleepiness and dizziness. While these side effects are important to know about, the study showed that Symbravo is generally safe for people to use on a regular basis.
Credits: Canva
The Tamil Nadu government has prohibited the manufacture, sale, distribution, and use of the cough syrup Almond Kit after laboratory testing confirmed it contained the highly toxic chemical ethylene glycol, according to a press release issued by the state’s drug control authority. Officials said the syrup, which is produced in Bihar, was found to be contaminated with ethylene glycol, a substance known to trigger serious and, in some cases, fatal health problems. But what exactly is ethylene glycol poisoning, and what health conditions can it cause?
The Tamil Nadu government has imposed a complete ban on the manufacture, sale, distribution, and consumption of the cough syrup Almond Kit after laboratory tests detected the presence of ethylene glycol, a highly dangerous chemical, the state drug control department said in a press statement. Citing news agency IANS, officials confirmed that the syrup is manufactured in Bihar and was found to be contaminated with ethylene glycol, a compound associated with severe and sometimes life-threatening health complications.
Ethylene glycol is a colourless, odourless liquid with a sweet taste, most commonly used in antifreeze. It may be consumed accidentally or intentionally, including in cases of self-harm. Once inside the body, ethylene glycol breaks down into glycolic acid and oxalic acid, which are responsible for most of its toxic effects.
According to Medline Plus, early symptoms of ethylene glycol poisoning include a feeling of intoxication, nausea, vomiting, and abdominal pain. As the poisoning progresses, symptoms can worsen and may include reduced consciousness, headaches, and seizures.
As per the US Centers for Disease Control and Prevention (CDC), exposure to ethylene glycol can result in severe and potentially fatal health conditions, particularly when ingested through contaminated medicines.
One of the most serious effects is acute kidney failure, which can develop rapidly and may cause the kidneys to shut down within a few days if treatment is delayed. Ethylene glycol can also harm the brain and nervous system, leading to confusion, poor coordination, seizures, and even coma.
The toxin can cause severe metabolic acidosis, a condition in which the blood becomes dangerously acidic, interfering with normal heart function and breathing.
In certain cases, ethylene glycol exposure can also lead to lung-related complications, including fluid accumulation in the lungs that makes breathing difficult.
Without prompt medical intervention, ethylene glycol poisoning can be fatal, especially in children and individuals with existing kidney or liver disease. This is why its detection in any oral medication is treated as a serious public health concern.
According to IANS, consumers have been advised to check for batch number AL24002 and strictly avoid using the syrup. People who already have the product have been asked to contact authorities for instructions on safe disposal. The Directorate has also stepped up inspections and monitoring across pharmacies and hospitals in Tamil Nadu to ensure the contaminated cough syrup is fully removed from circulation.
Credits: Canva
Finger-prick test for Alzheimer's could actually change its diagnosis. An international research trial is exploring if a simple finger-prick blood test could one day help diagnose Alzheimer's disease much earlier and more easily than current methods. The study has involved 1,000 volunteers aged over 60 from the UK, the UK, and Canada, and aims to detect biological markers in the blood linked to the condition.
If the test is successful, it could shift the Alzheimer's diagnosis. The test has the potential to make the diagnosis cheaper, which may not require expensive scans and invasive procedures.
Alzheimer's disease does not begin when memory problems become obvious. Research also shows that abnormal proteins linked to the disease, particularly amyloid and tau, can start building up in the brain more than a decade before symptoms appear.
By the time cognitive changes become noticeable, these damage may already occur. This is why such a test is important to ensure that the condition is diagnosed early. New treatments work best in early stages, which makes it more so important.
The trial is examining three specific proteins in the blood that have been strongly associated with Alzheimer’s disease. By measuring their levels and concentration, researchers hope to identify whether someone may be at risk, even before symptoms develop.
All volunteers are also undergoing existing gold-standard tests. These include specialized brain scans using radioactive tracers or lumbar punctures to collect cerebrospinal fluid. These methods are accurate but costly, time-consuming, and invasive. As a result, only a small fraction of patients currently receive them.
One of the biggest advantages of the finger-prick test is that it is simple. Unlike traditional blood tests, this test does not require needles, hospital visits or refrigeration. In the future, it could potentially be done at home, with samples mailed to a laboratory for analysis.
Experts say this could dramatically shorten the time it takes to receive an accurate diagnosis. Many families currently wait months or even years, often navigating multiple appointments before getting clear answers.
Participants have also chosen to take a part due to their personal experience with dementia in the families. For them, the possibility of early screening and new treatment is a way to avoid worsening the condition. Participants who have received negative results describe relief, while also recognizing that individual outcomes are just one part of a much larger study. Researchers will only know how effective the test truly is once data from all participants has been analyzed.
So far, 883 volunteers have enrolled, with more than 360 completing every test required. The group includes cognitively healthy individuals, people with mild impairment, and those in the early stages of Alzheimer’s. At least a quarter of participants come from under-represented communities. The trial is also expected to run until 2028.
Credits: AQI.in
After a brief period of clear sky, and better air quality index levels (AQI), Delhi is again engulfed with thick layer of smog. Delhiites on Monday morning woke up with the AQI of 418, under the 'severe' category. As per the data released by the Central Pollution Control Board (CPCB), the AQI in the ITO area was recorded 434, Rafi Marg at 417, and areas around Swaminarayan Akshardham temple at 455. All under 'severe' category.
Also Read: NHS England Expands Access To Life Saving Prostate Cancer Drug
The Commission for Air Quality Management (CAQM) imposed Stage IV of the Graded Response Action Plan (GRAP) on Saturday evening after AQI crossed the 400 mark for the first time in 2026. GRAP-IV is the strictest of all measures, and bans construction activities, along with restrictions on vehicle movement.
Under GRAP-IV, all petrol, diesel and CNG stations in Delhi will supply fuel to only vehicles with valid Pollution Under Control Certificate (PUCC).
Vehicles identified through ANPR cameras or other methods and found refuelled without PUCC will be facing penalties.
Verification of the physical certificates or electronic certificates would be done through systems like VAHAN.
Note: These rules do not apply on emergency vehicles on sovereign duty like ambulances, fire tenders and police vehicles. Vehicles carrying essential goods or providing essential services will be exempted too, notified by authorities.
Any vehicle registered outside Delhi and not compliant with BS-VI norms will not be allowed to operate in the city. CNG and electric vehicles, public transport, and vehicles carrying essential goods are exempted.
Trucks or any other carriers that transport construction materials like sand, stones, bricks, cement, ready-mix concrete, debris and similar items, will not be allowed to enter Delhi.
Under GRAP-IV, physical classes are suspended, and based on previous precedents, educational institutions were directed to shift to online or hybrid learning mode. GRAP-IV restrictions have been reimposed across Delhi and NCR residents, including Gurugram, Faridabad, Ghaziabad, and Gautam Budh Nagar.
Also Read: Delhi Isn't Just Breathing Toxic Air, But Also A Superbug That Resists Antibiotics
Delhi is not just breathing toxic air, but also a superbug through its air, which was found in a latest research conducted by the researchers are Jawaharlal Nehru University, published in Nature - Scientific Reports. Apart from the heavy particulate matter or the PM2.5, which are small enough to penetrate through one's bloodstream and cause blockage, Delhi's air also contains airborne bacteria, including staphylococci. The bacteria levels exceed the safety limit by 16-fold as provided by the World Health Organization (WHO).
The government is pursuing "smog eating" surfaces to deal with the pollution problem in Delhi. While it may sound like a strange thing in India, not to the world. In fact, in the Netherlands these were used to reduce local nitrogen oxide or the NO concentrations in the air, rather than greenhouse gas concentrations.
Smog usually contains a mixture of hydrocarbons, ozone, oxides of nitrogen and sulphur, and particulates. The pollution is caused by both photochemical reactions that involve sunlight, unburned hydrocarbons and nitrogen oxides, along with high concentrations of particulate matter, especially from vehicle exhaust, construction dust and biomass burning.
Read: Explained: What Are Smog-Eating Surface And How Is Delhi Using It To Beat Air Pollution
Environment Minister Manjinder Singh Sirsa announced "smog eating" surface as part of its pollution control plan, for which the government has also signed an MoU with IIT Madras.
The smog eating surfaces will be public surfaces coated with photocatalytic materials like titanium dioxide or TiO2 that is used to degrade pollutants.
Smog contains mainly nitric oxide, nitrogen dioxide, sulphur dioxide, ozone, and particulate matter. When all of these interact with photocatalytic materials, gaseous pollutants convert into less harmful compounds, such as nitrogen oxides become nitrates or decompose into ions. This process is also known as pollutant mineralization.
© 2024 Bennett, Coleman & Company Limited